Main content
'Not too late to review cost' of breast cancer drug Kadcyla
The NHS has rejected a drug that can extend lives of women with breast cancer because it is 鈥榯oo expensive鈥�. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.
Duration:
This clip is from
Featured in...
![]()
Health clips
Listen to a selection of clips from recent and upcoming programmes.
More clips from Today
-
![]()
'Everything has broken, leaked, gone mouldy or caught fire'
Duration: 04:31
-
![]()
Mason: PM sends Burnham a leadership contest warning
Duration: 05:24
-
![]()
Streeting could challenge the PM 'as early as next week'
Duration: 03:20
-
![]()
Thames Water moves step closer to nationalisation
Duration: 02:27
